Formulating the IP strategy
Where IP rights are already firmly anchored and applying for patents, designs, or trademarks is merely a routine matter, the conditions for the effective protection of intellectual property are good. As are those for the innovative capacity and competitiveness of a company. If this applies to yours, let’s talk! Because there’s more that we can do …
UPC Update - The new CMS is online
On July 8, the UPC has launched the first phase of its new CMS-rollout. Starting with limited functional scope, the new CMS is set to become fully operational in September.
G 1/23: No “Enablement” Hurdle for Prior Art Products Put on the Market – EPO Clarifies Scope of Prior Art
Enlarged Board of Appeal confirms: Commercially available products are prior art, even if they are not fully analyzable or reproducible
How the EPO addresses public prior use in clinical trials and patentability obstacles for pharmaceutical inventions
This article explores how the European Patent Office (EPO) addresses public prior use in the context of clinical trials.
IP strategies for the second funding round
As you scale, investors are looking at more than the potential of your IP, says Mathias Karlhuber. They now want to know whether it can support future growth and withstand any attacks.